Abstract:Detergent-solubilized bovine heart cytochrome c oxidase requires 2 mol of tightly bound cardiolipin (CL) per mole of monomeric complex for functional activity. Four lines of evidence support this conclusion: (1) Phospholipid depletion shows that two tightly bound CL's must remain associated with cytochrome c oxidase in order to maintain full electron transport activity. (2) Removal of the two tightly bound CL's correlates with decreased activity that is restored by reassociation of 2 mol of exogenous CL. (3) C… Show more
“…Bis-(AzC 12 )-CL photolabeling of monomeric, CL-containing CcO, which contains four filled CL binding sites, slightly decreased the yields of subunits VIIa, VIIb/ VIIc, and VIII ( Figure 5A), but the errors associated with these decreases were nearly as large as the values themselves. The poor labeling of these subunits is almost certainly due to incomplete exchange of bis-(AzC 12 )-CL for two endogenous CL that are tightly bound near these subunits ([ 14 C]-acetyl-CL binds at the two high-affinity sites only if the endogenous CL has been removed [13]). The inability of bis-(AzC 12 )-CL to exchange for endogenous CL would explain why the photolabeling of these subunits is not significantly higher than the nonspecific photolabeling of other transmembrane subunits, that is, subunits IV and VIc.…”
Section: Resultsmentioning
confidence: 99%
“…No other subunits dissociate from CcO upon removal of these tightly bound CL, but the resulting CL-free 11-subunit complex has only half of its original electron transport activity. Cardiolipin binding studies confirm the presence of two high-affinity and one or two lower-affinity binding sites (13). CcO, therefore, contains two types of CL binding sites: (1) two high-affinity sites that regulate electron transport and (2) one or two lower-affinity sites that stabilize subunits VIa and VIb and, therefore, CcO dimerization.…”
mentioning
confidence: 79%
“…The evidence for this second site is as follows. (1) Previous CL binding data indicate that two, not one, CLs bind to 11-subunit CL-free CcO (13). (2) Only subunits VIIa, VIIc, and possibly VIII are photolabeled by either arylazido-CL derivative.…”
Section: Cardiolipin Bound At Site Viia-bmentioning
Subunits located near the cardiolipin binding sites of bovine heart cytochrome c oxidase (CcO) were identified by photolabeling with arylazido-cardiolipin analogues and detecting labeled subunits by reversed-phase HPLC and HPLC-electrospray ionization mass spectrometry. Two arylazidocontaining cardiolipin analogues were synthesized: (1) 2-SAND-gly-CL with a nitrophenylazido group attached to the polar headgroup of cardiolipin (CL) via a linker containing a cleavable disulfide; (2) 2′,2″-bis-(AzC 12 )-CL with two of the four fatty acid tails of cardiolipin replaced by 12-(N-4-azido-2-nitrophenyl) aminododecanoic acid. Both arylazido-CL derivatives were used to map the cardiolipin binding sites within two types of detergent-solubilized CcO: (1) intact 13-subunit CLcontaining CcO (three to four molecules of endogenous CL remain bound per CcO monomer); (2) 11-subunit CL-free CcO (subunits VIa and VIb are missing because they dissociate during CL removal). Upon the basis of these photolabeling studies, we conclude that (1) subunits VIIa, VIIc, and possibly VIII are located near the two high-affinity cardiolipin binding sites, which are present in either form of CcO, and (2) subunit VIa is located adjacent to the lower affinity cardiolipin binding site, which is only present in the 13-subunit form of CcO. These data are consistent with the recent CcO crystal structure in which one cardiolipin is located near subunit VIIa and a second is located near subunit VIa (PDB ID code 1V54 referenced in Tomitake, T. et al. (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 15304−15309). However, we propose that a third cardiolipin is bound between subunits VIIa and VIIc near the entrance to the D-channel. Cardiolipin bound at this location could potentially function as a proton antenna to facilitate proton entry into the D-channel. If true, it would explain the CcO requirement of bound cardiolipin for full electron transport activity.Cardiolipin (diphosphatidylglycerol, CL 1 ) is a unique phospholipid found in membranes that couple electron transport to oxidative phosphorylation, for example, mitochondrial inner membrane and bacterial cytoplasmic membrane (2-4). In eukaryotes, CL is synthesized exclusively within the mitochondrion and is found only in the mitochondrial inner membrane. The structure of CL is quite different from other phospholipids. It contains three glycerols, two
“…Bis-(AzC 12 )-CL photolabeling of monomeric, CL-containing CcO, which contains four filled CL binding sites, slightly decreased the yields of subunits VIIa, VIIb/ VIIc, and VIII ( Figure 5A), but the errors associated with these decreases were nearly as large as the values themselves. The poor labeling of these subunits is almost certainly due to incomplete exchange of bis-(AzC 12 )-CL for two endogenous CL that are tightly bound near these subunits ([ 14 C]-acetyl-CL binds at the two high-affinity sites only if the endogenous CL has been removed [13]). The inability of bis-(AzC 12 )-CL to exchange for endogenous CL would explain why the photolabeling of these subunits is not significantly higher than the nonspecific photolabeling of other transmembrane subunits, that is, subunits IV and VIc.…”
Section: Resultsmentioning
confidence: 99%
“…No other subunits dissociate from CcO upon removal of these tightly bound CL, but the resulting CL-free 11-subunit complex has only half of its original electron transport activity. Cardiolipin binding studies confirm the presence of two high-affinity and one or two lower-affinity binding sites (13). CcO, therefore, contains two types of CL binding sites: (1) two high-affinity sites that regulate electron transport and (2) one or two lower-affinity sites that stabilize subunits VIa and VIb and, therefore, CcO dimerization.…”
mentioning
confidence: 79%
“…The evidence for this second site is as follows. (1) Previous CL binding data indicate that two, not one, CLs bind to 11-subunit CL-free CcO (13). (2) Only subunits VIIa, VIIc, and possibly VIII are photolabeled by either arylazido-CL derivative.…”
Section: Cardiolipin Bound At Site Viia-bmentioning
Subunits located near the cardiolipin binding sites of bovine heart cytochrome c oxidase (CcO) were identified by photolabeling with arylazido-cardiolipin analogues and detecting labeled subunits by reversed-phase HPLC and HPLC-electrospray ionization mass spectrometry. Two arylazidocontaining cardiolipin analogues were synthesized: (1) 2-SAND-gly-CL with a nitrophenylazido group attached to the polar headgroup of cardiolipin (CL) via a linker containing a cleavable disulfide; (2) 2′,2″-bis-(AzC 12 )-CL with two of the four fatty acid tails of cardiolipin replaced by 12-(N-4-azido-2-nitrophenyl) aminododecanoic acid. Both arylazido-CL derivatives were used to map the cardiolipin binding sites within two types of detergent-solubilized CcO: (1) intact 13-subunit CLcontaining CcO (three to four molecules of endogenous CL remain bound per CcO monomer); (2) 11-subunit CL-free CcO (subunits VIa and VIb are missing because they dissociate during CL removal). Upon the basis of these photolabeling studies, we conclude that (1) subunits VIIa, VIIc, and possibly VIII are located near the two high-affinity cardiolipin binding sites, which are present in either form of CcO, and (2) subunit VIa is located adjacent to the lower affinity cardiolipin binding site, which is only present in the 13-subunit form of CcO. These data are consistent with the recent CcO crystal structure in which one cardiolipin is located near subunit VIIa and a second is located near subunit VIa (PDB ID code 1V54 referenced in Tomitake, T. et al. (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 15304−15309). However, we propose that a third cardiolipin is bound between subunits VIIa and VIIc near the entrance to the D-channel. Cardiolipin bound at this location could potentially function as a proton antenna to facilitate proton entry into the D-channel. If true, it would explain the CcO requirement of bound cardiolipin for full electron transport activity.Cardiolipin (diphosphatidylglycerol, CL 1 ) is a unique phospholipid found in membranes that couple electron transport to oxidative phosphorylation, for example, mitochondrial inner membrane and bacterial cytoplasmic membrane (2-4). In eukaryotes, CL is synthesized exclusively within the mitochondrion and is found only in the mitochondrial inner membrane. The structure of CL is quite different from other phospholipids. It contains three glycerols, two
“…For instance, the presence of bound cardiolipin is essential for full activity of the ADP/ATP carrier (26), cytochrome c oxidase (27), and the cytochrome bc 1 complex (28,29). The high-resolution structures of bound cardiolipin(s) have been described for the cytochrome bc 1 complex (30).…”
We have synthesized ∆lac-acetogenins that are new acetogenin mimics possessing two n-alkyl tails without an R, -unsaturated γ-lactone ring and suggested that their inhibition mechanism may be different from that of common acetogenins [Hamada et al. (2004) Biochemistry 43, 3651-3658]. To elucidate the inhibition mechanism of ∆lac-acetogenins in more detail, we carried out wide structural modifications of original ∆lac-acetogenins and characterized the inhibitory action with bovine heart mitochondrial complex I. In contrast to common acetogenins, both the presence of adjacent bis-THF rings and the stereochemistry around the hydroxylated bis-THF rings are important structural factors required for potent inhibition. The inhibitory potency of a derivative possessing an n-butylphenyl ether structure (compound 7) appeared to be superior to that of the original ∆lac-acetogenins and equivalent to that of bullatacin, one of the most potent natural acetogenins. Double-inhibitor titration of steady-state complex I activity showed that the extent of inhibition of compound 7 and bullatacin is not additive, suggesting that the binding sites of the two inhibitors are not identical. Competition tests using a fluorescent ligand indicated that the binding site of compound 7 does not overlap with that of other complex I inhibitors. The effects of compound 7 on superoxide production from complex I are also different from those of other complex I inhibitors. Our results clearly demonstrate that ∆lac-acetogenins are a novel type of inhibitor acting at the terminal electron-transfer step of bovine complex I.
“…Thus, a detailed understanding of the regulation of CL levels will provide important insights into the manifestation of these conditions. CL is associated with major proteins of the mitochondrial respiratory chain including NADH dehydrogenase (complex I) (13), ubiquinol:cytochrome c reductase (complex III) (13)(14)(15)(16)(17), and cytochrome c oxidase (complex IV) (18,19), the ATP synthase (complex V) (20), and the carrier proteins for phosphate (21) and adenine nucleotides (22). CL modulates the catalytic activities of proteins, as seen in the case of the ADP-ATP carrier (5,23,24) and complex IV (25), and/or provides stability as reported for complex III (17) and complex IV (19).…”
Cardiolipin (CL) is an acidic phospholipid present almost exclusively in membranes harboring respiratory chain complexes. We have previously shown that, in Saccharomyces cerevisiae, CL provides stability to respiratory chain supercomplexes and CL synthase enzyme activity is reduced in several respiratory complex assembly mutants. In the current study, we investigated the interdependence of the mitochondrial respiratory chain and CL biosynthesis. Pulse-labeling experiments showed that in vivo CL biosynthesis was reduced in respiratory complexes III (ubiquinol:cytochrome c oxidoreductase) and IV (cytochrome c oxidase) and oxidative phosphorylation complex V (ATP synthase) assembly mutants. CL synthesis was decreased in the presence of CCCP, an inhibitor of oxidative phosphorylation that reduces the pH gradient but not by valinomycin or oligomycin, both of which reduce the membrane potential and inhibit ATP synthase, respectively. The inhibitors had no effect on phosphatidylglycerol biosynthesis or CRD1 gene expression. These results are consistent with the hypothesis that in vivo CL biosynthesis is regulated at the level of CL synthase activity by the ⌬pH component of the proton-motive force generated by the functional electron transport chain. This is the first report of regulation of phospholipid biosynthesis by alteration of subcellular compartment pH.
Cardiolipin (CL)1 is an acidic glycerophospholipid with a unique dimeric structure consisting of four fatty acyl chains (1). It is almost exclusively present in membranes designed to generate an electrochemical potential gradient for ATP synthesis, including the mitochondrial inner membrane and bacterial plasma membrane. CL plays a vital role in mitochondrial structure and function by providing osmotic stability to mitochondrial membranes (2) and by specifically interacting with many inner membrane proteins (reviewed in Refs. 3 and 4). Normal levels of CL are required for optimal mitochondrial bioenergetic functions (5, 6). Decreased CL levels are observed in cells undergoing apoptosis (7-9) and aging (10, 11) and in fibroblasts of Barth syndrome patients (12). Thus, a detailed understanding of the regulation of CL levels will provide important insights into the manifestation of these conditions. CL is associated with major proteins of the mitochondrial respiratory chain including NADH dehydrogenase (complex I) (13), ubiquinol:cytochrome c reductase (complex III) (13-17), and cytochrome c oxidase (complex IV) (18, 19), the ATP synthase (complex V) (20), and the carrier proteins for phosphate (21) and adenine nucleotides (22). CL modulates the catalytic activities of proteins, as seen in the case of the ADP-ATP carrier (5, 23, 24) and complex IV (25), and/or provides stability as reported for complex III (17) and complex IV (19). CL binds specifically and irreversibly to cytochrome c (26), providing a membrane attachment site for cytochrome c and limiting the soluble pool of the protein. X-ray crystallography studies have further confirmed the specific interaction...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.